GT Metabolic Solutions clinical trials
GT Metabolic Solutions is the lead sponsor of 7 current clinical trials in our Canada, USA, Spain, Italy, Czechia and Portugal registers. 5 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Semaglutide. The most-studied condition is Gastric Outlet Obstruction.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by GT Metabolic Solutions
7 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Magnet System Gastric Outlet Obstruction Study
NCT07609511 · Gastric Outlet Obstruction
|
Not applicable | Recruiting | 2026-09 | Czechia |
|
Creation of Compression Anastomosis Using the GT Metabolic Magnet System
NCT07431723 · ClinicalTrials.gov ↗ · Anastomosis, Functional, Colorectal
|
Not applicable | Recruiting | 2026-02 | Spain, Italy |
|
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
NCT07317115 · ClinicalTrials.gov ↗ · Obesity (Disorder), Obesity & Overweight, Type 2 Diabetes (T2DM)
Drug: Semaglutide |
Not applicable | Recruiting | 2026-03 | Canada |
|
GT Metabolic Magnet System in Adults With Gastrointestinal Disorders
NCT07317076 · ClinicalTrials.gov ↗ · Gastric Outlet Obstruction, Small Bowel Obstruction, Superior Mesenteric Artery Syndrome
|
Not applicable | Recruiting | 2025-12 | Canada |
|
MagDI U.S. Registry
NCT06928545 · Anastomosis, Surgical, Internal Hernia, Bowel Obstruction
|
Observational | Recruiting | 2025-03 | USA |
|
Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")
NCT06073457 · Obesity, Type 2 Diabetes
|
Not applicable | Active, closed | 2023-11 | Portugal, Canada |
|
MagDI Canada Study
NCT06467955 · ClinicalTrials.gov ↗ · Obesity, Type 2 Diabetes
|
Not applicable | Active, closed | 2024-05 | Canada |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in GT Metabolic Solutions trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in GT Metabolic Solutions trials
13 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Canada | 4 | 2 |
| Clinical trials in USA | 1 | 1 |
| Clinical trials in Spain | 1 | 1 |
| Clinical trials in Italy | 1 | 1 |
| Clinical trials in Czechia | 1 | 1 |
| Clinical trials in Portugal | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Questions about GT Metabolic Solutions trials
How many clinical trials does GT Metabolic Solutions sponsor?
GT Metabolic Solutions is the lead sponsor of 7 current trials on ClinicalTrials.gov in our Canada, USA, Spain, Italy, Czechia and Portugal registers, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.
Are GT Metabolic Solutions trials recruiting?
Yes. 5 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is GT Metabolic Solutions testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Semaglutide (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.